ALT-801(Altor BioScience)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameALT-801(Altor BioScience)
Drug Alias Name264scTCR/IL-2
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor protein p53 stimulantsInterleukin-2 stimulants
TargetsTumor protein p53Interleukin-2
Therapy Area/IndicationsUrinary Bladder NeoplasmsUrethral NeoplasmsUreteral Neoplasms +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAltor Bioscience Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNantkwest IncAltor Bioscience Corp
Active IndicationsN/A
Inactive IndicationsUrinary Bladder NeoplasmsUrethral NeoplasmsUreteral Neoplasms +[8] 

Other Information

ATC CodeN/A
Related LinksN/A